B
Belite Bio, Inc (BLTE)
NCM – Real Time Price. Currency in USD
155.54
+3.57 (2.35%)
At close: May 12, 2026, 4:00 PM EDT
156.50
+0.96 (0.62%)
After-hours: May 12, 2026, 4:18 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
155.54
+3.57 (2.35%)
At close: May 12, 2026, 4:00 PM EDT
156.50
+0.96 (0.62%)
After-hours: May 12, 2026, 4:18 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $352.9M significantly exceed its total debt $429.0K, ensuring strong financial flexibility
Total current assets $494.3M exceed Total current liabilities $9.9M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 50.02 | 6.05 | 10 | |
| Quick ratio | 50.02 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -198K | -399K | -449K | -464K | -117K |
| Operating Income | -13M | -32M | -40M | -84M | -84M |
| Net Income | -13M | -32M | -36M | -78M | -78M |
| EBITDA | -13M | -31M | -40M | -84M | -84M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -41.08 | 1.0 |
| Next quarter | N/A | -32.55 | 1.0 |
| Current year | N/A | 5.78 | 3.0 |
| Next year | 808.01 | 144.57 | 10 |
| Weighted average score | 3.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -16.74 | 41.54 | N/A | 5.5 |
| Y/Y | 999 | -150.72 | -18.74 | N/A | 3.3 |
| 3y average | 999 | -93.01 | -61.25 | -58.89 | 3.3 |
| 5y average | 999 | -75.57 | -61.25 | -60.56 | 3.3 |
| Weighted average score | 3.9 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |